Keyword

Question

HAP, VAP, and HCAP – Definition and mechanisms
Q01 Defining HAP, VAP, and HCAP
Q02 Incidence of HAP, VAP, and HCAP
Q03 Mechanisms involved in developing HAP
Q04 The diagnostic features
Q05 Diagnostic approach and treatment

Mortality/morbidity associated with HAP/ VAP
Q06 Mortality and morbidity rates
Q07 Factors affect the mortality/ morbidity

Etiologic factors associated with HAP, VAP, and HCAP
Q08 Etiologic pathogens responsible for HAP, VAP, and HCAP
Q09 Factors promoting antimicrobial resistance
Q10 Microbiologic etiology for HAP, VAP, and HCAP

HAP/ VAP and medical costs
Q11 Effect of HAP/VAP on medical costs

Antibiotic therapy for HAP, VAP, and HCAP
Q12 Initial selection of antibiotic therapy
Q13 Clinical outcomes
Q14 The features of fluoloquinolones
Q15 Combination therapy vs. monotherapy
Q16 Dosing of antibiotics for HAP, VAP, and HCAP

Prevention and management of HAP, VAP, and HCAP
Q17 Prevention of HAP, VAP, and HCAP
Q18 Optimal management of HAP, VAP, and HCAP

References

©1998- BIOMEDIS International, Ltd. All rights reserved. Reproduction in any manner in whole or part prohibited.
Disclaimer